Company News

Lupin receives USFDA nod for Generic Topicort LP Emollient Cream


Pharma Major Lupin Limited (Lupin) announced that it has received final approval for its Desoximetasone Cream USP, 0.05% and Desoximetasone Cream USP, 0.25% from the United States Food and Drug Administration (FDA) to market a generic equivalent of Taro Pharmaceuticals North America, Incs Topicort LP Emollient Cream, 0.05% and Taro Pharmaceuticals, Incs (collectively Taro) Topicort® Cream, 0.25%.

Both products are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Topicort® LP emollient Cream had US sales of USD 33 mn (IMS MAT September 2016) while Topicort Cream had US sales of USD 17 mn (IMS MAT September 2016).


Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Follow us on

Most Popular

200000+ Subscribers read it every day.
Subscribe Newsletter
To Top